Skip to main content
Signal8

Eversept Partners, LP

Eversept Partners, LP is a Mutual Fund institutional filer with the SEC under CIK 1697013, reporting 115 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Eversept Partners, LP's most recent 13F filing, ranked by reported market value.

  1. UNITED THERAPEUTICS CORP DEL (UTHR)
  2. ABIVAX SA (ABVX)
  3. ENCOMPASS HEALTH CORP (EHC)
  4. ENSIGN GROUP INC (ENSG)
  5. VERA THERAPEUTICS INC (VERA)
  6. CELLDEX THERAPEUTICS INC NEW (CLDX)
  7. SYNDAX PHARMACEUTICALS INC (SNDX)
  8. BROOKDALE SR LIVING INC (BKD)
  9. IONIS PHARMACEUTICALS INC (IONS)
  10. NATERA INC (NTRA)
/